Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001415889-15-001719
Filing Date
2015-05-14
Accepted
2015-05-14 16:41:30
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cocp10q_mar312015.htm 10-Q 595247
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER (302) ex31-1.htm EX-31.1 11369
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER (302) ex31-2.htm EX-31.2 12123
4 CERTIFICATION OF PRINCIPAL EXECUTIVE AND PRINCIPAL FINANCIAL OFFICER ex32-1.htm EX-32.1 8069
  Complete submission text file 0001415889-15-001719.txt   3487178

Data Files

Seq Description Document Type Size
5 cocp-20150331.xml EX-101.INS 370546
6 cocp-20150331.xsd EX-101.SCH 35222
7 cocp-20150331_cal.xml EX-101.CAL 38491
8 cocp-20150331_def.xml EX-101.DEF 117409
9 cocp-20150331_lab.xml EX-101.LAB 205031
10 cocp-20150331_pre.xml EX-101.PRE 189942
Mailing Address 19805 NORTH CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 NORTH CREEK PARKWAY BOTHELL WA 98011 (425) 398-7178
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

EIN.: 205978559 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55158 | Film No.: 15863515
SIC: 2834 Pharmaceutical Preparations